Sort
64,565 grants matching “drug discovery”
HBV Capsid Effectors
$635,652Raymond F. Schinazi · Emory University · R56 · FY2021 · AI
Identification of neutralizing epitopes on SARS-CoV-2 spike for design of vaccines and small-molecule antivirals
$635,619Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2021 · AI
Roles of Noncoding RNA in Bone Regeneration
$635,562Jake Jinkun Chen · Tufts University Boston · R01 · FY2022 · DE
Knee OA: Setting Priorities for Care, Policy, Research
$635,544Elena Losina · Brigham And Women'S Hospital · R01 · FY2006 · AR
Discovery of Natural Products and Natural Product-Like Inhibitors
$635,515Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
A phenotypic screen for compounds that differentially affect excitatory and inhibitory neuronal signaling
$635,498Steven John Ryan · Quiver Bioscience Inc. · R44 · FY2023 · MH
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
$635,495Pembe Hande Ozdinler · Northwestern University At Chicago · R01 · FY2020 · AG
Small molecules targeting RhoA for platelet cold storage in cancer care
$635,494Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · HL
Small molecules targeting RhoA for platelet cold storage in cancer care
$635,494Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · HL
Small molecules targeting RhoA for platelet cold storage in cancer care
$635,494Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HL
Small molecules targeting RhoA for platelet cold storage in cancer care
$635,494Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL
Optimization of glucocorticoid receptor (GR) passive antagonists for the treatment of post-traumatic stress disorder (PTSD)
$635,352Anthony Bruce Pinkerton · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · MH
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies
$635,332Joshua Wiley Knowles · Stanford University · R01 · FY2021 · DK
Functional characterization of SSRI resistant genes using C. elegans
$635,305Ji Y Sze · Albert Einstein College Of Medicine · R01 · FY2010 · MH
Salmonella-specific therapeutics
$635,257Brian M Ahmer · Ohio State University · R01 · FY2021 · AI
Bioprinting 3D skin for patient-specific drug discovery in inflammatory skin diseases.
$635,200Angela M Christiano · Columbia University Health Sciences · U18 · FY2017 · TR
Microtubule Regulation
$635,178Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R01 · FY2011 · GM
HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS
$635,173Tufts University Boston · R33 · FY2002 · CA
T-cell subsets as CVD risk factors in CHS and MESA
$635,172Bruce M Psaty · University Of Washington · R01 · FY2016 · HL
Combine computational prediction, network analysis and genetic screening in C elegans to uncover neurodegenerative causes in Alzheimer's Disease
$635,171Rong Xu · Case Western Reserve University · R01 · FY2018 · AG
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE)
$635,073Shelley Lusetti · New Mexico State University Las Cruces · P20 · FY2024 · GM
Coarse-to-fine Discovery for Genetic Association
$635,000Donald J Geman · Johns Hopkins University · · FY2012 · MPS
Medicinal Chemistry
$634,978Craig Lindsley · Vanderbilt University · U01 · FY2010 · MH
A Bioengineering Approach to Develop a Laminar 3D Cerebellar Neuronal Circuit for Modeling Human Cerebellum
$634,977Kathleen Joyce Millen · Seattle Children'S Hospital · R01 · FY2022 · NS
Synthesis and Evaluation of Functionally Biased Opioid Analgesics
$634,972Laura M Bohn · Scripps Florida · R01 · FY2012 · DA